Substituted anilines as CCR(4) antagonists
US8835419B2 · kind B2 · utility
7Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2012 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Jan 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.